Nonetheless, in ovarian cancer cells, GULP1 showed inhibitory effects on their proliferation while inducing phospho-SMAD3 [27] or reducing phosphorylation of AKT/PDK1 and MAPK [28]. Here, SMAD3 is linked to ovarian carcinoma.